Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.

BACKGROUND/AIMS Specific markers are required for early detection and diagnosis of intrahepatic cholangiocarcinoma (ICC); however, the tumour markers currently in use are not specific for ICC. METHODS We compared an ICC cDNA library with that of hepatocellular carcinoma (HCC) by serial analysis of gene expression (SAGE). The expression patterns in each were confirmed by quantitative real-time reverse transcriptase-polymerase chain reaction (RT-PCR), immunoblotting and immunohistochemical analysis of 74 samples including 16 ICC samples. RESULTS A comparison of the two libraries revealed distinct gene expression patterns for each type of liver cancer. In addition to the known tumour markers, we detected nine novel genes associated with ICC. By comparing the mean transcript abundance in the ICC library with those in other libraries, including gastric, colon, prostate and breast cancer, together with our RT-PCR results, we identified three genes as specific markers of ICC: biglycan, insulin-like growth factor-binding protein 5 and claudin-4. Immunoblotting and immunohistochemical analyses showed that claudin-4 was highly expressed in ICC. Moreover, discrimination analysis revealed that a combination of these genes could be used to distinguish ICC from HCC or metastatic adenocarcinoma. CONCLUSIONS We identified novel marker genes of ICC that are potentially useful for the diagnosis of liver cancer.

[1]  Y. Nakajima,et al.  Annexin II overexpression correlates with stromal tenascin‐C overexpression , 2001, Cancer.

[2]  F. Schaffner,et al.  Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas. , 1989, Archives of pathology & laboratory medicine.

[3]  M. Makuuchi,et al.  IHPBA concordant classification of primary liver cancer: working group report. , 2003, Journal of hepato-biliary-pancreatic surgery.

[4]  K. Danielson,et al.  The murine biglycan: complete cDNA cloning, genomic organization, promoter function, and expression. , 1995, Genomics.

[5]  H. Thomas,et al.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.

[6]  H. Thomas,et al.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours. , 2002, Journal of hepatology.

[7]  B. Oral,et al.  CD24 expression is a poor prognostic marker in endometrial carcinoma. , 2006, European Journal of Gynaecological Oncology.

[8]  S. Kawasaki,et al.  Matrix metalloproteinase‐7 expression and biologic aggressiveness of cholangiocellular carcinoma , 2002, Cancer.

[9]  H. El‐Serag,et al.  Cholangiocarcinoma: the “other” liver cancer on the rise , 2002, American Journal of Gastroenterology.

[10]  I. Kovalszky,et al.  Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas , 2006, Modern Pathology.

[11]  T. Patel.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States , 2001, Hepatology.

[12]  M. Honda,et al.  α‐fetoprotein‐producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis , 2001 .

[13]  A. Schauer,et al.  Antibodies to intermediate filaments as diagnostic tools: human gastrointestinal carcinomas express prekeratin. , 1982, Laboratory investigation; a journal of technical methods and pathology.

[14]  J. Bernaudin,et al.  Real‐time RT‐PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma , 2005, International journal of cancer.

[15]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein-5 Inhibits the Growth of Human Breast Cancer Cells in Vitro and in Vivo* , 2003, Journal of Biological Chemistry.

[16]  J. Marrero,et al.  Newer markers for hepatocellular carcinoma. , 2004, Gastroenterology.

[17]  K. Ohuchida,et al.  S100A11, A Putative Tumor Suppressor Gene, Is Overexpressed in Pancreatic Carcinogenesis , 2006, Clinical Cancer Research.

[18]  J. Katahira,et al.  Clostridium perfringens Enterotoxin Utilizes Two Structurally Related Membrane Proteins as Functional Receptors in Vivo * , 1997, The Journal of Biological Chemistry.

[19]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.

[20]  K. Matsushima,et al.  Comprehensive gene expression profile of a normal human liver. , 2000, Biochemical and biophysical research communications.

[21]  Y. Nakajima,et al.  Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. , 2001, Anticancer research.

[22]  M. Honda,et al.  alpha-fetoprotein-producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis. , 2001, Hepatology.

[23]  J. Vishwanatha,et al.  Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts. , 1992, Cancer research.

[24]  M. Honda,et al.  Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays , 2001, Hepatology.

[25]  M. Tsuneyoshi,et al.  Combined hepatocellular and cholangiocarcinoma: proposed criteria according to cytokeratin expression and analysis of clinicopathologic features. , 1995, Human pathology.

[26]  H. El‐Serag,et al.  The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.

[27]  G. Gores.  Cholangiocarcinoma: Current concepts and insights , 2003, Hepatology.

[28]  Zuo-Feng Zhang,et al.  Dietary Selenium Intake and Genetic Polymorphisms of the GSTP1 and p53 Genes on the Risk of Esophageal Squamous Cell Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[29]  Kenichi Kobayashi,et al.  Serial analysis of gene expression in chronic hepatitis C and hepatocellular carcinoma. , 2001, Biochemical and biophysical research communications.

[30]  Wei Zhang,et al.  PMEPA1, an androgen-regulated NEDD4-binding protein, exhibits cell growth inhibitory function and decreased expression during prostate cancer progression. , 2003, Cancer research.

[31]  M. Kojiro,et al.  Establishment and characterization of a new human extrahepatic bile duct carcinoma cell line (KMBC) , 1992, Cancer.

[32]  R. Warnke,et al.  The Diagnostic Utility of the Keratin Profiles of Hepatocellular Carcinoma and Cholangiocarcinoma , 1988, The American journal of surgical pathology.

[33]  R. Lichtinghagen,et al.  Expression Pattern of Matrix Metalloproteinases in Human Liver , 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[34]  K. Schwarz,et al.  Expression of biglycan, decorin and proteoglycan-100/CSF-1 in normal and fibrotic human liver. , 1997, Pathology, research and practice.

[35]  A. Hoeflich,et al.  IGF-binding protein-5: flexible player in the IGF system and effector on its own. , 2002, The Journal of endocrinology.

[36]  H. Thomas,et al.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998 , 2001, Gut.

[37]  S. Yoon,et al.  S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.